MD Anderson (Again) On Topof U.S. News and World Report Ranking

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The U.S. News & World Report rankings of the best cancer hospitals for 2016 brought no great surprises. The top four cancer centers did not change from last year:

1) MD Anderson Cancer Center,

2) Memorial Sloan Kettering Cancer Center,

3) Mayo Clinic, Rochester, Minn. and

4) Dana-Farber/Brigham and Women’s Cancer Center.

There was a change in this year’s No. 5 slot: UCLA Medical Center. Last year, it was the Seattle Cancer Alliance and University of Washington Medical Center

Though the system used by U.S. News isn’t regarded as scientific, directors of cancer centers and folks in marketing pay close attention to even the smallest of changes in the standing of their institutions.

As in the past, the rankings are determined largely by a metric called “reputation with specialists,” which contributes 27.5 percent to the overall grade. You calculate that score by posing the following question to board-certified oncologists:

“Please name up to five U.S. hospitals that you believe provide the best care in oncology for patients who have the most challenging conditions or who need particularly difficult procedures. Do not consider location or cost.”

In oncology, the results are predictable: MD Anderson and MSKCC get mentioned first, and a steep drop-off follows. This year, MD Anderson had the reputation score of 62, MSKCC got 61.1, Mayo 33.5, Dana Farber/Brigham and Women’s 26.3, and UCLA 6.8. MD Anderson has been in the top position 12 times over the past 15 years.

Tables show that many NCI-designated cancer centers end up with barely detectable “reputation with specialists” scores.

The 2016 table appears below:

art 42-31 2016 table

This can be compared with last year’s table:

art 41-29 2015 table

The reputational score was determined by a survey of two separate cohorts:

• The Doximity Masterfile member survey, which was conducted with 9,672 cancer specialists, of whom 9.6 percent responded.

• Surveys were also sent to 200 oncologists who are not Doximity members; 28.4 percent of whom responded.

The results were stratified by census region, weighted, put through log transformation and averaged over three years.

The Cancer Letter’s previous coverage of the U.S. News and World Report cancer hospital rankings:

Paul Goldberg
Editor & Publisher
Laura Brawley
Laura Brawley
Conor Hale
Conor Hale

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.
Paul Goldberg
Editor & Publisher
Laura Brawley
Laura Brawley
Conor Hale
Conor Hale

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login